Newsfile Corp
20 Nov 2026, 11:30 UTC · 1h ago
Telo Genomics Corp. Announces Non-Brokered Private Placement of Secured Convertible Debentures
Impact · against what's priced in
Telo Genomics is raising $1 million through secured convertible debentures, which provides immediate liquidity but introduces potential equity dilution. The net impact is slightly negative as the long-term risk of share dilution outweighs the modest capital infusion.
- TELO−0.20
No priced-in read yet





